Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn
COVID-19 raises the risk of cardiovascular disease in people with HIV
Greater weight gain in first year of HIV treatment raises risks of diabetes, metabolic syndrome and precursors of heart disease
Users of TAF in PrEP more likely to develop high blood pressure or need statins
More evidence that non-alcoholic fatty liver disease raises cardiovascular risk in people with HIV
Top 5 stories on co-infections and co-morbidities in people with HIV from IAS 2023
Top 5 stories on HIV in Africa from IAS 2023
Statins and HIV: how can the REPRIEVE findings be implemented in the real world?
Diagnosis and treatment for high blood pressure need to be funded as part of HIV treatment programmes
